Location: East Midlands
Location: North West England
Location: South East Coast
Speciality: Pharmacy Technician
A no-deal Brexit may force the public to stockpile medicines, pharmaceutical industry leaders have told MPs.
Speaking to the House of Commons' Health and Social Care Committee, Martin Sawer of the Healthcare Distributors Association said the industry may not have the capacity to stockpile sufficient drugs, meaning members of the public might need to buy in bulk themselves.
He remarked: "We need politicians to understand there could be consequences. We are not suggesting anybody needs to stockpile outside of the supply chain yet. But come January that might be a different picture.
"We are, we believe, going to be in a difficult situation if there is not a deal by Christmas."
He suggested that the government might have to use emergency powers, which could include permitting pharmacists to swap one drug for another without requiring the consent of GPs, based on what is available.
Chief executive of the Association of the British Pharmaceutical Industry Mike Thompson issued a similar warning, telling MPs that stockpiling by pharmaceutical firms "won't be enough," and that the government needs to make some firmer contingency plans.
However, a Department of Health and Social Care spokesman has said patients should not seek to stockpile drugs, asserting that the government is "confident" of still getting a deal. In the meantime, he stated, plans are being made to "ensure adequate stockpiles" are there in the event of a no-deal outcome.
Prime minister Theresa May has said the UK is 95 per cent of the way to a deal with the EU, but the question of the Irish border remains a sticking point.
Although imported drugs will come not from Ireland but across the Channel, the issue of freedom of goods and services to move between the EU and Britain is central to the Irish border question.
Pharmaceutical firms Novartis and Sanofi both revealed in the summer that they were making contingency plans in case of a no-deal Brexit.
Written by James Puckle
Search Mediplacements for the latest pharmacy jobs.
According to the National Migraine Centre, one in seven people around the globe are affected by migraines,...
The NHS has made a new offer to a drug company to provide medicine for potentially thousands of cystic fibrosis...
Spinal muscular atrophy (SMA) is a rare genetic disease that up until now has had no treatment for the underlying...
Primary progressive multiple sclerosis (PPMS) is a rare form of MS that affects less than 15 per cent of people...